Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Duen Shian Wang"'
Publikováno v:
2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
Autor:
J. Trae Hampton, Duen Shian Wang, Jin Liu, Wenshe R. Liu, Sukant K. Das, Jeffery M. Tharp, Xiaoshan Shayna Wang, Catrina A. Reed, Peng Hsun Chase Chen, Yang Shen, Hamed S. Hayatshahi
Publikováno v:
Angew Chem Int Ed Engl
Superior to linear peptides in biological activities, cyclic peptides are considered to have great potentials used as therapeutic agents. In order to identify cyclic peptide ligands for therapeutic targets, selection from phage-displayed peptide libr
Autor:
Ka Yi Lau, Duen Shian Wang, Ming Hung Hu, Kuen-Feng Chen, Chia Han Lee, Chunyu Liu, Chung Wai Shiau, Ming Huang Chen, Ling Ming Tseng, Wan-Lun Wang, Chun Teng Huang, Hsiu Ping Yang, Tzu Ting Huang, Wen Chun Tsai
Publikováno v:
European Journal of Cancer. 72:112-123
Objectives Cancerous inhibitor of protein phosphatase 2A (CIP2A) has emerged as a therapeutic determinant mediating the anti-cancer effects of several new agents. We investigated the efficacy and mechanism of TD52, an erlotinib derivative with minima
Autor:
Chung Wai Shiau, Ming Huang Chen, Ling Ming Tseng, Duen Shian Wang, Chia Jung Hsu, Kuen-Feng Chen, Ming Hung Hu, Yi Ting Chen, Chunyu Liu, Wen Chun Tsai, Pei-Yi Chu, Chia Han Lee, Chia Chi Hsu, Chun Teng Huang
Publikováno v:
Oncotarget
We tested the efficacy of lapatinib, a dual tyrosine kinase inhibitor which interrupts the HER2 and epidermal growth factor receptor (EGFR) pathways, in a panel of triple-negative breast cancer (TNBC) cells, and examined the drug mechanism. Lapatinib
Autor:
Wei-Tien Tai, Chunyu Liu, Yuan-Ping Kao, Pei-Yi Chu, Man-Hsin Hung, Kuen-Feng Chen, Chung Wai Shiau, Mei-Huei Ni, Ling-Ming Tseng, Duen-Shian Wang, Jung-Chen Su
Publikováno v:
Breast Cancer Research and Treatment. 146:71-84
Interfering oncogenic STAT3 signaling is a promising anti-cancer strategy. We examined the efficacy and drug mechanism of an obatoclax analog SC-2001, a novel STAT3 inhibitor, in human breast cancer cells. Human breast cancer cell lines were used for
Autor:
Ling Ming Tseng, Chun Teng Huang, Ming Hung Hu, Yi Ting Chen, Chunyu Liu, Ming Huang Chen, Chia Han Lee, Chia Jung Hsu, Pei-Yi Chu, Chung Wai Shiau, Duen Shian Wang, Wen Chun Tsai, Kuen-Feng Chen, Chia Chi Hsu
Publikováno v:
Oncotarget
We tested the efficacy of lapatinib, a dual tyrosine kinase inhibitor which interrupts the HER2 and epidermal growth factor receptor (EGFR) pathways, in a panel of triple-negative breast cancer (TNBC) cells, and examined the drug mechanism. Lapatinib
Autor:
Duen-Shian Wang, 王敦賢
99
Studying developmental processes is important for science advancement and medical treatment. The complex processes involved in organism development require many sets of signaling transduction pathways for proper spatial and temporal regulatio
Studying developmental processes is important for science advancement and medical treatment. The complex processes involved in organism development require many sets of signaling transduction pathways for proper spatial and temporal regulatio
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/4njphj
Autor:
Chia-Jung Hsu, Duen-Shian Wang, Chunyu Liu, Kuen-Feng Chen, Ling-Min Tseng, Jung-Chen Su, Chung Wai Shiau
Publikováno v:
Cancer Research. 74:2778-2778
Background: Triple-negative breast cancer (TNBC) is a subtype with aggressive behaviors and poor prognosis. Our previous study has shown that CIP2A, cancerous inhibitor of PP2A, may be a novel target in breast cancer cells (Breast Cancer Research 201
Publikováno v:
Cancer Research. 73:914-914
Background: Tamoxifen is an antagonist of the estrogen receptor (ER) in breast tissue and has been a standard anti-estrogen agent in hormone receptor-positive breast cancers. Previous studies have indicated that tamoxifen also induces estrogen recept
Autor:
Chun-Yu Liu, Man-Hsin Hung, Duen-Shian Wang, Pei-Yi Chu, Jung-Chen Su, Tsung-Han Teng, Chun-Teng Huang, Ting-Ting Chao, Cheng-Yi Wang, Chung-Wai Shiau, Ling-Ming Tseng, Kuen-Feng Chen
Publikováno v:
Breast Cancer Research; 2014, Vol. 16 Issue 5, p1-30, 30p, 1 Color Photograph, 2 Charts, 4 Graphs